Progress in vaccination for histoplasmosis and blastomycosis: Coping with cellular immunity

References

• Mochon AB, Cutler JE. Is a vaccine needed against Candida albicans?. Med Mycol 2005; 43: 97–115
   PubMed Web of Science ®Google Scholar
• Deepe, GS, Jr, Seder, RA. Molecular and cellular determinants of immunity to Histoplasma capsulatum. Res Immunol 1998; 149: 397–406.
   Google Scholar
• Chang WL, Audet RG, Aizenstein BD, et al. T-Cell epitopes and human leukocyte antigen restriction elements of an immunodominant antigen of Blastomyces dermatitidis. Infect Immun 2000; 68: 502–510
   PubMed Web of Science ®Google Scholar
• Deepe, GS, Jr. Immune response to early and late Histoplasma capsulatum infections. Curr Opin Microbiol 2000; 3: 359–362.
   Google Scholar
• Cole GT, Xue JM, Okeke CN, et al. A vaccine against coccidioidomycosis is justified and attainable. Med Mycol 2004; 42: 189–216
   PubMed Web of Science ®Google Scholar
• Finkel-Jimenez B, Wuthrich M, Brandhorst T, Klein BS. The WI-1 adhesin blocks phagocyte TNF-alpha production, imparting pathogenicity on Blastomyces dermatitidis. J Immunol 2001; 166: 2665–2673
   PubMed Web of Science ®Google Scholar
• Finkel-Jimenez B, Wuthrich M, Klein BS. BAD1, an essential virulence factor of Blastomyces dermatitidis, suppresses host TNF-α production through TGF-β-dependent and -independent mechanisms. J Immunol 2002; 168: 5746–5755
   PubMed Web of Science ®Google Scholar
• Allendoerfer, R, Deepe, GS, Jr. Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice. Infect Immun 1997; 65: 2564–2569.
   PubMed Web of Science ®Google Scholar
• Allendoerfer, R, Deepe, GS, Jr. Blockade of endogenous TNF-α exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J Immunol 1998; 160: 6072–6082.
   PubMed Web of Science ®Google Scholar
• Allendoerfer, R, Boivin, GP, Deepe, GS, Jr. Modulation of immune responses in murine pulmonary histoplasmosis. J Infect Dis 1997; 175: 905–914.
   PubMed Web of Science ®Google Scholar
• Wuthrich M, Finkel-Jiminez BE, Klein BS. Interleukin 12 as an adjuvant to WI-1 adhesin immunization augments delayed-type hypersensitivity, shifts the subclass distribution of immunoglobulin G antibodies, and enhances protective immunity to Blastomyces dermatitidis infection. Infect Immun 2000; 68: 7172–7174
   Google Scholar
• Wuthrich M, Filutowicz HI, Warner T, Klein BS. Requisite elements in vaccine immunity to Blastomyces dermatitidis: plasticity uncovers vaccine potential in immune-deficient hosts. J Immunol 2002; 169: 6969–6976
   Google Scholar
• Zhou P, Sieve MC, Bennett J, et al. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ. J Immunol 1995; 155: 785–795
   PubMed Web of Science ®Google Scholar
• Zhou P, Miller G, Seder RA. Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-α plays a critical role in maintaining secondary immunity in the absence of IFN-γ. J Immunol 1998; 160: 1359–1368
   PubMed Web of Science ®Google Scholar
• Zhou P, Sieve MC, Tewari RP, Seder RA. Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum. Infect Immun 1997; 65: 936–942
   PubMed Web of Science ®Google Scholar
• Wu-Hsieh BA, Lee GS, Franco M, Hofman FM. Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice. Infect Immun 1992; 60: 4230–4238
   PubMedGoogle Scholar
• Wu-Hsieh BA, Howard DH. Intracellular growth inhibition of Histoplasma capsulatum induced in murine macrophages by recombinant gamma interferon is not due to a limitation of the supply of methionine or cysteine to the fungus. Infect Immun 1992; 60: 698–700
   Google Scholar
• Smith JG, Magee DM, Williams DM, Graybill JR. Tumor necrosis factor-alpha plays a role in host defense against Histoplasma capsulatum. J Infect Dis 1990; 162: 1349–1353
   PubMedGoogle Scholar
• Medeiros AI, Silva CL, Malheiro A, Maffei CM, Faccioli LH. Leukotrienes are involved in leukocyte recruitment induced by live Histoplasma capsulatum or by the beta-glucan present in their cell wall. Br J Pharmacol 1999; 128: 1529–1537
   PubMedGoogle Scholar
• Newman SL, Gootee L, Gabay JE, Selsted ME. Identification of constituents of human neutrophil azurophil granules that mediate fungistasis against Histoplasma capsulatum. Infect Immun 2000; 68: 5668–5672
   PubMed Web of Science ®Google Scholar
• Couto MA, Liu L, Lehrer RI, Ganz T. Inhibition of intracellular Histoplasma capsulatum replication by murine macrophages that produce human defensin. Infect Immun 1994; 62: 2375–2378
   Google Scholar
• Deepe, GS, Jr, Gibbons, R. Recombinant murine granulocyte-macrophage colony-stimulating factor modulates the course of pulmonary histoplasmosis in immunocompetent and immunodeficient mice. Antimicrob Agents Chemother 2000; 44: 3328–3336.
   Google Scholar
• Deepe, GS, Jr, Gibbons, R, Woodward, E. Neutralization of endogenous granulocyte-macrophage colony-stimulating factor subverts the protective immune response to Histoplasma capsulatum. J Immunol 1999; 163: 4985–4993.
   Google Scholar
• Allendoerfer, R, Deepe, GS, Jr. Regulation of infection with Histoplasma capsulatum by TNFR1 and -2. J Immunol 2000; 165: 2657–2664.
   PubMed Web of Science ®Google Scholar
• Garcia JP, Howard DH. Characterization of antigens from the yeast phase of Histoplasma capsulatum. Infect Immun 1971; 4: 116–125
   Google Scholar
• Tewari RP, Sharma D, Solotorovsky M, Lafemina R, Balint J. Adoptive transfer of immunity from mice immunized with ribosomes or live yeast cells of Histoplasma capsulatum. Infect Immun 1977; 15: 789–795
   PubMedGoogle Scholar
• Salvin SB. Immunization of mice against Histoplasma capsulatum. Public Health Monogr 1956; 70: 107–109
   Google Scholar
• Gomez, AM, Rhodes, JC, Deepe, GS, Jr. Antigenicity and immunogenicity of an extract from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun 1991; 59: 330–336.
   PubMedGoogle Scholar
• Gomez, FJ, Gomez, AM, Deepe, GS, Jr. Protective efficacy of a 62-kilodalton antigen, HIS-62, from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun 1991; 59: 4459–4464.
   PubMed Web of Science ®Google Scholar
• Gomez, FJ, Allendoerfer, R, Deepe, GS, Jr. Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis. Infect Immun 1995; 63: 2587–2595.
   PubMed Web of Science ®Google Scholar
• Blander SJ, Horwitz MA. Major cytoplasmic membrane protein of Legionella pneumophila, a genus common antigen and member of the hsp 60 family of heat shock proteins, induces protective immunity in a guinea pig model of Legionnaires’ disease. J Clin Invest 1993; 91: 717–723
   Google Scholar
• Hoffman PS, Houston L, Butler CA. Legionella pneumophila htpAB heat shock operon: nucleotide sequence and expression of the 60-kilodalton antigen in L. pneumophila-infected HeLa cells. Infect Immun 1990; 58: 3380–3387
   PubMedGoogle Scholar
• Bullock WE, Wright SD. Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages. J Exp Med 1987; 165: 195–210
   PubMed Web of Science ®Google Scholar
• Newman SL, Bucher C, Rhodes J, Bullock WE. Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest 1990; 85: 223–230
   PubMed Web of Science ®Google Scholar
• Long KH, Gomez FJ, Morris RE, Newman SL. Identification of heat shock protein 60 as the ligand on Histoplasma capsulatum that mediates binding to CD18 receptors on human macrophages. J Immunol 2003; 170: 487–494
   PubMed Web of Science ®Google Scholar
• Brandhorst T, Klein B. Cell wall biogenesis of Blastomyces dermatitidis. Evidence for a novel mechanism of cell surface localization of a virulence-associated adhesin via extracellular release and reassociation with cell wall chitin. J Biol Chem 2000; 275: 7925–7934
   PubMed Web of Science ®Google Scholar
• Deepe, GS, Jr, Gibbons, R, Brunner, GD, Gomez, FJ. A protective domain of heat-shock protein 60 from Histoplasma capsulatum. J Infect Dis 1996; 174: 828–834.
   PubMedGoogle Scholar
• Gomez, FJ, Gomez, AM, Deepe, GS, Jr. An 80-kilodalton antigen from Histoplasma capsulatum that has homology to heat shock protein 70 induces cell-mediated immune responses and protection in mice. Infect Immun 1992; 60: 2565–2571.
   Google Scholar
• Allendoerfer, R, Maresca, B, Deepe, GS, Jr. Cellular immune responses to recombinant heat shock protein 70 from Histoplasma capsulatum. Infect Immun 1996; 64: 4123–4128.
   Google Scholar
• Deepe, GS, Jr, Durose, GG. Immunobiological activity of recombinant H antigen from Histoplasma capsulatum. Infect Immun 1995; 63: 3151–3157.
   PubMed Web of Science ®Google Scholar
• Deepe, GS, Jr, Gibbons, R. Protective efficacy of H antigen from Histoplasma capsulatum in a murine model of pulmonary histoplasmosis. Infect Immun 2001; 69: 3128–3134.
   PubMed Web of Science ®Google Scholar
• Sa-Nunes A, Medeiros AI, Nicolete R, et al. Efficacy of cell-free antigens in evaluating cell immunity and inducing protection in a murine model of histoplasmosis. Microbes Infect 2005; 7: 584–592
   Google Scholar
• Nosanchuk, JD, Steenbergen, JN, Shi, L, Deepe, GS, Jr, Casadevall, A. Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. J Clin Invest 2003; 112: 1164–1175.
   PubMed Web of Science ®Google Scholar
• Deepe, GS, Jr, Gibbons, RS. Cellular and molecular regulation of vaccination with heat shock protein 60 from Histoplasma capsulatum. Infect Immun 2002; 70: 3759–3767.
   Google Scholar
• Luo W, Fine J, Garg M, Kaplan AM, Bondada S. Interleukin-10 enhances immune responses to pneumococcal polysaccharides and sheep erythrocytes in young and aged mice. Cell Immunol 1999; 195: 1–9
   Google Scholar
• Kaufman HL, Rao JB, Irvine KR, et al. Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model. J Immunother 1999; 22: 489–496
   PubMed Web of Science ®Google Scholar
• Fujii S, Shimizu K, Shimizu T, Lotze MT. Interleukin-10 promotes the maintenance of antitumor CD8+ T-cell effector function in situ. Blood 2001; 98: 2143–2151
   PubMed Web of Science ®Google Scholar
• Scheckelhoff, M, Deepe, GS, Jr. The protective immune response to heat shock protein 60 of Histoplasma capsulatum is mediated by a subset of Vβ 8.1/8.2+ T cells. J Immunol 2002; 169: 5818–5826.
   PubMed Web of Science ®Google Scholar
• Scheckelhoff, M, Deepe, GS, Jr. A deficiency in gamma interferon or interleukin-10 modulates T-cell-dependent responses to heat shock protein 60 from Histoplasma capsulatum. Infect Immun 2005; 73: 2129–2134.
   Google Scholar
• Deepe, GS, Jr, Gibbons, R. Vβ 6+ T cells are obligatory for vaccine-induced immunity to Histoplasma capsulatum. J Immunol 2001; 167: 2219–2226.
   Google Scholar
• Deepe, GS, Jr, Gibbons, RS. Functional properties of the T cell receptor repertoire in responding to the protective domain of heat-shock protein 60 from Histoplasma capsulatum. J Infect Dis 2002; 186: 815–822.
   Google Scholar
• Klein BS, Sondel PM, Jones JM. WI-1, a novel 120-kilodalton surface protein on Blastomyces dermatitidis yeast cells, is a target antigen of cell-mediated immunity in human blastomycosis. Infect Immun 1992; 60: 4291–4300
   PubMed Web of Science ®Google Scholar
• Klein BS, Jones JM. Isolation, purification, and radiolabeling of a novel 120-kD surface protein on Blastomyces dermatitidis yeasts to detect antibody in infected patients. J Clin Invest 1990; 85: 152–161
   PubMed Web of Science ®Google Scholar
• Hogan LH, Josvai S, Klein BS. Genomic cloning, characterization, and functional analysis of the major surface adhesin WI-1 on Blastomyces dermatitidis yeasts. J Biol Chem 1995; 270: 30725–30732
   PubMed Web of Science ®Google Scholar
• Newman SL, Chaturvedi S, Klein BS. The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 [CR3] and CD14. J Immunol 1995; 154: 753–761
   PubMed Web of Science ®Google Scholar
• Brandhorst T, Wuthrich M, Finkel-Jimenez B, Klein B. A C-terminal EGF-like domain governs BAD1 localization to the yeast surface and fungal adherence to phagocytes, but is dispensable in immune modulation and pathogenicity of Blastomyces dermatitidis. Mol Microbiol 2003; 48: 53–65
   PubMed Web of Science ®Google Scholar
• Wiedemann A, Linder S, Grassl G, et al. Yersinia enterocolitica invasin triggers phagocytosis via beta1 integrins, CDC42Hs and WASp in macrophages. Cell Microbiol 2001; 3: 693–702
   PubMed Web of Science ®Google Scholar
• Brandhorst TT, Wuthrich M, Warner T, Klein B. Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis. J Exp Med 1999; 189: 1207–1216
   PubMed Web of Science ®Google Scholar
• Brandhorst TT, Wuthrich M, Finkel-Jimenez B, Warner T, Klein BS. Exploiting type 3 complement receptor for TNF-( suppression, immune evasion, and progressive pulmonary fungal infection. J Immunol 2004; 173: 7444–7453
   PubMed Web of Science ®Google Scholar
• Wuthrich M, Chang WL, Klein BS. Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis. Infect Immun 1998; 66: 5443–5449
   PubMedGoogle Scholar
• Wuthrich M, Klein BS. Investigation of anti-WI-1 adhesin antibody-mediated protection in experimental pulmonary blastomycosis. J Infect Dis 2000; 181: 1720–1728
   Google Scholar
• Wuthrich M, Filutowicz HI, Klein BS. Mutation of the WI-1 gene yields an attenuated Blastomyces dermatitidis strain that induces host resistance. J Clin Invest 2000; 106: 1381–1389
   PubMed Web of Science ®Google Scholar
• Wuthrich, M, Filutowicz, HI, Warner, T, Deepe, GS, Jr, Klein, BS. Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts. J Exp Med 2003; 197: 1405–1416.
   PubMed Web of Science ®Google Scholar